JP2021513558A5 - - Google Patents
Info
- Publication number
- JP2021513558A5 JP2021513558A5 JP2020564795A JP2020564795A JP2021513558A5 JP 2021513558 A5 JP2021513558 A5 JP 2021513558A5 JP 2020564795 A JP2020564795 A JP 2020564795A JP 2020564795 A JP2020564795 A JP 2020564795A JP 2021513558 A5 JP2021513558 A5 JP 2021513558A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- hypertonic pharmaceutical
- composition according
- hypertonic
- platinum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024081711A JP2024098070A (ja) | 2018-02-09 | 2024-05-20 | 抗白金化学保護剤を含む高張医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862628824P | 2018-02-09 | 2018-02-09 | |
| US62/628,824 | 2018-02-09 | ||
| PCT/US2019/017334 WO2019157370A1 (en) | 2018-02-09 | 2019-02-08 | Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024081711A Division JP2024098070A (ja) | 2018-02-09 | 2024-05-20 | 抗白金化学保護剤を含む高張医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021513558A JP2021513558A (ja) | 2021-05-27 |
| JP2021513558A5 true JP2021513558A5 (https=) | 2022-02-15 |
| JP7492917B2 JP7492917B2 (ja) | 2024-05-30 |
Family
ID=67549759
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020564795A Active JP7492917B2 (ja) | 2018-02-09 | 2019-02-08 | 抗白金化学保護剤を含む高張医薬組成物 |
| JP2024081711A Pending JP2024098070A (ja) | 2018-02-09 | 2024-05-20 | 抗白金化学保護剤を含む高張医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024081711A Pending JP2024098070A (ja) | 2018-02-09 | 2024-05-20 | 抗白金化学保護剤を含む高張医薬組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US10709732B2 (https=) |
| EP (1) | EP3749309A4 (https=) |
| JP (2) | JP7492917B2 (https=) |
| KR (1) | KR102860981B1 (https=) |
| CN (1) | CN112020359A (https=) |
| AU (1) | AU2019218232B2 (https=) |
| BR (1) | BR112020016059A2 (https=) |
| CA (1) | CA3090783A1 (https=) |
| IL (1) | IL276569B2 (https=) |
| MX (2) | MX2020008323A (https=) |
| SG (1) | SG11202007595WA (https=) |
| WO (1) | WO2019157370A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3510161A4 (en) | 2016-08-23 | 2020-04-22 | Akouos, Inc. | COMPOSITIONS AND METHODS FOR TREATING PERSONAL HEARING LOSS IN A PERSON |
| CN112020359A (zh) | 2018-02-09 | 2020-12-01 | 分贝治疗公司 | 含有抗铂化学保护剂的高渗药物组合物 |
| CN112805238A (zh) * | 2018-07-03 | 2021-05-14 | 芬内克制药股份有限公司 | 无水硫代硫酸钠和其调配物 |
| US20220054640A1 (en) * | 2018-12-11 | 2022-02-24 | Decibel Therapeutics, Inc. | Compositions and methods for the delivery of therapeutic agents across the round window membrane |
| US10813947B1 (en) | 2019-05-31 | 2020-10-27 | Decibel Therapeutics, Inc. | Methods of otoprotection against platinum-based antineoplastic agents |
| US20220296637A1 (en) * | 2019-06-19 | 2022-09-22 | Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis | Sodium thiosulfate gel for preventing or reducing hearing loss |
| WO2021087408A1 (en) * | 2019-10-30 | 2021-05-06 | Otonomy, Inc. | Otic formulations for drug-induced ototoxicity |
| KR20220157944A (ko) | 2020-02-21 | 2022-11-29 | 아카우오스, 인크. | 인간 대상체에서 비-연령-연관 청각 장애를 치료하기 위한 조성물 및 방법 |
| US20260027327A1 (en) | 2024-07-26 | 2026-01-29 | Regeneron Pharmaceuticals, Inc. | Otic drug delivery system and methods |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6649621B2 (en) | 1997-12-16 | 2003-11-18 | The United States Of America As Represented By The Secretary Of The Navy | Prevention or reversal of sensorineural hearing loss (SNHL) through biologic mechanisms |
| US6497902B1 (en) | 1999-12-01 | 2002-12-24 | The Regents Of The University Of Michigan | Ionically crosslinked hydrogels with adjustable gelation time |
| US7022315B2 (en) | 2000-04-26 | 2006-04-04 | Oregon Health & Science University | Administration of a thiol-based chemoprotectant compound |
| US20040186172A1 (en) * | 2001-07-02 | 2004-09-23 | Houssam Ibrahim | Oxaliplatin active substance with a very low content of oxalic acid |
| EP1799232B1 (en) | 2004-10-12 | 2015-10-07 | FMC Biopolymer AS | Self-gelling alginate systems and uses thereof |
| KR101271263B1 (ko) | 2005-09-28 | 2013-06-07 | 아우리스 메디칼 아게 | 내이 장애 치료용 약학 조성물 |
| CA2668864A1 (en) | 2006-11-09 | 2008-05-15 | Takeda Pharmaceutical Company Limited | Pharmaceutical composition comprising a dihydrobenzofuranyl isoindoline and a lipophilic component |
| EP2278999B1 (en) | 2008-04-21 | 2025-01-29 | Dompé farmaceutici S.p.A. | Auris formulations for treating otic diseases and conditions |
| US8784870B2 (en) | 2008-07-21 | 2014-07-22 | Otonomy, Inc. | Controlled release compositions for modulating free-radical induced damage and methods of use thereof |
| US20100016450A1 (en) | 2008-07-21 | 2010-01-21 | Otonomy, Inc. | Controlled release delivery devices for the treatment of otic disorders |
| US8496957B2 (en) | 2008-07-21 | 2013-07-30 | Otonomy, Inc | Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
| AU2010270605B2 (en) | 2009-07-08 | 2014-07-31 | Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals | Sodium thiosulfate-containing pharmaceutical compositions |
| WO2012112810A1 (en) | 2011-02-18 | 2012-08-23 | Otonomy, Inc. | Prevention of and recovery from drug-induced ototoxicity |
| US10130514B2 (en) | 2011-09-26 | 2018-11-20 | Incube Labs, Llc | System and method for delivery of a therapeutic agent to the inner ear |
| FR2992861B1 (fr) * | 2012-07-09 | 2014-10-17 | Probionov | Utilisation de thiosulfate pour potentialiser l'effet anti-pathogene des lactobacilles |
| BR112017025499A2 (pt) * | 2015-05-28 | 2018-08-07 | Baylor College Medicine | benefícios da suplementação com n-acetil cisteína e glicina para melhorar os níveis de glutationa |
| HK1252531A1 (zh) | 2015-08-05 | 2019-05-31 | Children's Medical Center Corporation | 用於药物递送的具有渗透增强剂的组合物 |
| AU2017218437A1 (en) | 2016-02-10 | 2018-08-23 | Cocoon Biotech Inc. | Compositions including benzenesulfonamide-containing non-steroidal anti-inflammatory drugs silk fibroin and a gelling agent and uses thereof |
| AU2017290256A1 (en) | 2016-06-29 | 2019-01-17 | Otonomy, Inc. | Triglyceride otic formulations and uses thereof |
| EP3570826A4 (en) | 2017-01-19 | 2020-09-23 | Otologic Pharmaceutics, Inc. | N-ACETYLCYSTEIN FORMULATIONS AND THEIR USES |
| US10596190B2 (en) | 2017-11-29 | 2020-03-24 | Oregon Health & Science University | Method for reducing ototoxicity in pediatric patients receiving platinum-based chemotherapy |
| WO2019118330A1 (en) | 2017-12-12 | 2019-06-20 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Thermoresponsive hydrogel containing polymer microparticles for controlled drug delivery to the ear |
| US11918653B2 (en) | 2017-12-22 | 2024-03-05 | Dompé Farmaceutici S.P.A. | Triglyceride otic formulations and uses thereof |
| US10946443B2 (en) | 2018-01-08 | 2021-03-16 | Hamilton Sundstrand Corporation | Removal of unfused powder from an additive-manufactured part using piezoelectric transducers |
| WO2019140012A1 (en) | 2018-01-09 | 2019-07-18 | Otonomy, Inc. | Growth factor otic formulations |
| WO2019154895A1 (en) | 2018-02-08 | 2019-08-15 | Strekin Ag | Gel formulation for preventing or treating hearing loss |
| CN112020359A (zh) | 2018-02-09 | 2020-12-01 | 分贝治疗公司 | 含有抗铂化学保护剂的高渗药物组合物 |
| EP3810146A4 (en) | 2018-04-25 | 2022-08-17 | Otonomy, Inc. | OTIC FORMULATIONS FOR DRUG-INDUCED OTOTOXICITY |
| IT201800006566A1 (it) | 2018-06-21 | 2019-12-21 | Composizione per prevenire e trattare disordini uditivi e vestibolari | |
| CN112805238A (zh) | 2018-07-03 | 2021-05-14 | 芬内克制药股份有限公司 | 无水硫代硫酸钠和其调配物 |
| US10813947B1 (en) | 2019-05-31 | 2020-10-27 | Decibel Therapeutics, Inc. | Methods of otoprotection against platinum-based antineoplastic agents |
| US20220296637A1 (en) | 2019-06-19 | 2022-09-22 | Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis | Sodium thiosulfate gel for preventing or reducing hearing loss |
-
2019
- 2019-02-08 CN CN201980023532.8A patent/CN112020359A/zh active Pending
- 2019-02-08 MX MX2020008323A patent/MX2020008323A/es unknown
- 2019-02-08 BR BR112020016059-8A patent/BR112020016059A2/pt unknown
- 2019-02-08 SG SG11202007595WA patent/SG11202007595WA/en unknown
- 2019-02-08 WO PCT/US2019/017334 patent/WO2019157370A1/en not_active Ceased
- 2019-02-08 JP JP2020564795A patent/JP7492917B2/ja active Active
- 2019-02-08 KR KR1020207026015A patent/KR102860981B1/ko active Active
- 2019-02-08 EP EP19751242.9A patent/EP3749309A4/en active Pending
- 2019-02-08 CA CA3090783A patent/CA3090783A1/en active Pending
- 2019-02-08 AU AU2019218232A patent/AU2019218232B2/en active Active
- 2019-07-19 US US16/517,284 patent/US10709732B2/en active Active
-
2020
- 2020-07-13 US US16/927,777 patent/US11071751B2/en active Active
- 2020-08-06 IL IL276569A patent/IL276569B2/en unknown
- 2020-08-07 MX MX2023001963A patent/MX2023001963A/es unknown
-
2021
- 2021-06-21 US US17/352,712 patent/US11857567B2/en active Active
-
2023
- 2023-11-30 US US18/524,148 patent/US20240350533A1/en not_active Abandoned
-
2024
- 2024-05-20 JP JP2024081711A patent/JP2024098070A/ja active Pending
-
2025
- 2025-03-31 US US19/096,329 patent/US20250381219A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021513558A5 (https=) | ||
| TW201717973A (zh) | 無刺激性眼用聚乙烯吡咯啶酮-碘組成物 | |
| US11986491B2 (en) | Pharmaceutical compositions comprising iodine and steroid and uses thereof for sinus diseases | |
| CN103096908B (zh) | 喷鼻剂 | |
| PT739197E (pt) | Composicoes de farmacos oftalmicos conservados contendo compostos de amonio quaternario polimericos | |
| JPWO2004064828A1 (ja) | ２−アミノ−３−（４−ブロモベンゾイル）フェニル酢酸含有水性液剤 | |
| JP2012520882A5 (https=) | ||
| JP2017002035A5 (https=) | ||
| JP2008024700A (ja) | ベルベリン含有水性組成物 | |
| CN103260616B (zh) | 对乙酰氨基酚的稳定化剂 | |
| CA3042729A1 (en) | In situ gel-forming pharmaceutical compositions and uses thereof for sinus diseases | |
| JP2023505255A5 (https=) | ||
| ES2301807T3 (es) | Compuestos de amoniociclodextrina cuaternizados. | |
| JP5201795B2 (ja) | 掻痒抑制剤 | |
| NO339109B1 (no) | Konserverende sammensetning for oftalmisk anvendelse | |
| JP2010120968A (ja) | 眼科用組成物、防腐剤、防腐力向上剤及び防腐力向上方法 | |
| JP2013536257A5 (https=) | ||
| JP2024512121A5 (https=) | ||
| JP4752987B2 (ja) | 外用剤組成物 | |
| ES2697343T3 (es) | Formulación de gel que comprende agentes analgésicos y anestésicos | |
| JP2007522077A (ja) | 粘膜の疾患および障害の予防および処置のための液体製剤 | |
| BR112020016597A2 (pt) | Composição aquosa, usos de pelo menos um solvente orgânico, método para preparar uma composição, garrafa e kit | |
| CN110785162A (zh) | 用于治疗青光眼的滴眼液组合物 | |
| JP5572110B2 (ja) | 粘膜の疾患および障害の予防および処置のための液体製剤 | |
| CN115137699B (zh) | 一种增效防腐的右美托咪定鼻喷剂 |